학술논문

Ixekizumab and Ustekinumab Efficacy in Nail Psoriasis in Patients with Moderate-to-Severe Psoriasis: 52-Week Results from a Phase 3, Head-to-Head Study (IXORA-S)
Document Type
Article
Source
In: Dermatology and Therapy. (Dermatology and Therapy, 1 August 2020, 10(4):663-670)
Subject
Language
English
ISSN
21909172
21938210